Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and NailsAmerican Journal of Clinical Dermatology - Tập 19 - Trang 31-39 - 2018
Mario Lacouture, Vincent Sibaud
Targeted therapies and immunotherapies are associated with a wide range of dermatologic adverse events (dAEs) resulting from common signaling pathways involved in malignant behavior and normal homeostatic functions of the epidermis and dermis. Dermatologic toxicities include damage to the skin, oral mucosa, hair, and nails. Acneiform rash is the most common dAE, observed in 25–85% of patients trea...... hiện toàn bộ
EfalizumabAmerican Journal of Clinical Dermatology - Tập 10 - Trang 51-72 - 2012
James E. Frampton, Greg L. Plosker
Efalizumab (Raptiva®) is a recombinant, humanized, monoclonal antibody that targets CD11a, the a-subunit of the heterodimeric lymphocyte surface protein lymphocyte function-associated antigen-1 (LFA-1). It is approved for the treatment of adult patients (aged ≥ 18 years) with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy (in the US), or who hav...... hiện toàn bộ
Important Controversies Associated with Isotretinoin Therapy for AcneAmerican Journal of Clinical Dermatology - Tập 14 - Trang 71-76 - 2013
Stephen E. Wolverton, Julie C. Harper
Isotretinoin is a remarkably effective drug for severe, recalcitrant acne vulgaris. Soon after the drug’s release in the early 1980s, a number of important adverse effects were reported subsequently leading to a variety of medical and medicolegal controversies. Three of these controversies will be highlighted concerning the putative role of isotretinoin in (1) depression and suicide, (2) inflammat...... hiện toàn bộ
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic ReviewAmerican Journal of Clinical Dermatology - Tập 23 - Trang 605-613 - 2022
Mette Gyldenløve, Farzad Alinaghi, Claus Zachariae, Lone Skov, Alexander Egeberg
The evidence for adding small-molecule drugs to an ongoing biologic treatment is sparse, but combination therapies appear to be advantageous in appropriately selected patients with psoriasis. To our knowledge, efficacy and safety of combination therapy with apremilast and biologics has not previously been reviewed. A literature search was performed on Medline (PubMed), Embase, Web of Science, and ...... hiện toàn bộ
A Comprehensive Review of the Long-Term and Short-Term Treatment of Melasma with a Triple Combination CreamAmerican Journal of Clinical Dermatology - Tập 7 - Trang 223-230 - 2012
Helen M. Torok
Melasma is a common disorder of hyperpigmentation and generally involves areas of the face and neck. Hyperpigmentation is especially prevalent in darker complected patients and is often difficult to treat. Hydroquinone, tretinoin, and topical corticosteroids are well established monotherapeutic agents for treating melasma and hyperpigmentation; however, a stable, once-daily formulation triple comb...... hiện toàn bộ
Multikinase Inhibitor-Induced Hand–Foot Skin Reaction: A Review of Clinical Presentation, Pathogenesis, and ManagementAmerican Journal of Clinical Dermatology - Tập 17 - Trang 387-402 - 2016
Kumutnart Chanprapaph, Suthinee Rutnin, Vasanop Vachiramon
Multikinase inhibitors (MKIs) are targeted cancer therapies designed to inhibit multiple tyrosine kinase pathways responsible for tumor proliferation, growth, and survival. These agents are more able to target cancer cells and possess better safety profiles than conventional chemotherapies. However, MKIs can produce significant cutaneous adverse events, hand–foot skin reaction (HFSR) being the mos...... hiện toàn bộ